Metabolic syndrome is becoming a global epidemic disease, and it has been an important cause or risk factor for chronic liver disease in China. Recently, many studies have shown that metabolic syndrome is not only the important cause or risk factor for non-alcoholic fatty liver disease, but also closely associated with increased incidence of cirrhosis and liver cancer in patients with alcoholic liver disease, chronic hepatitis B and C, and cryptogenic liver disease. Moreover, chronic liver disease patients with metabolic syndrome have a significantly increased risk of type 2 diabetes and arteriosclerotic cardiovascular disease. These results suggest that hepatologists should pay more attention to the clinical research on the relationship be...
The prevalence of diabetes is increasing rapidly in China. However, evidence is limited about its ef...
Non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MS) are two different entities sha...
The conventional paradigm of nonalcoholic fatty liver disease representing the "hepatic manifestatio...
Summary The association of metabolic disorders with liver disease is receiving increasing attention ...
Chronic liver diseases and metabolic disorders represent two real public health problems that cause ...
In the last few years several clinical and epidemiological studies have convincingly associated nona...
Abstract Background Previous studies have suggested that metabolic syndrome (MetS) and its component...
The association of metabolic disorders with liver disease is receiving increasing attention in the g...
Metabolic syndrome is closely associated with chronic hepatitis C. On one hand, hepatitis C virus pl...
CONTEXT: Non-alcoholic fatty liver disease (NAFLD), hepatic manifestation of metabolic syndrome, has...
Aim of the study is to review scientific articles, regarding non-alcoholic fatty liver disease relat...
Over the last few years, the paradigm in hepatology has changed from focusing on a single liver dise...
Abbreviations: ALT = alanine aminotransferase, BMI = body-mass index, CHB = chronic hepatitis B, CHC...
<div><p>Objectives</p><p>To explore the relationship between non-alcoholic fatty liver disease (NAFL...
Metabolic syndrome (MetS) is a disease composed of different risk factors such as obesity, type 2 di...
The prevalence of diabetes is increasing rapidly in China. However, evidence is limited about its ef...
Non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MS) are two different entities sha...
The conventional paradigm of nonalcoholic fatty liver disease representing the "hepatic manifestatio...
Summary The association of metabolic disorders with liver disease is receiving increasing attention ...
Chronic liver diseases and metabolic disorders represent two real public health problems that cause ...
In the last few years several clinical and epidemiological studies have convincingly associated nona...
Abstract Background Previous studies have suggested that metabolic syndrome (MetS) and its component...
The association of metabolic disorders with liver disease is receiving increasing attention in the g...
Metabolic syndrome is closely associated with chronic hepatitis C. On one hand, hepatitis C virus pl...
CONTEXT: Non-alcoholic fatty liver disease (NAFLD), hepatic manifestation of metabolic syndrome, has...
Aim of the study is to review scientific articles, regarding non-alcoholic fatty liver disease relat...
Over the last few years, the paradigm in hepatology has changed from focusing on a single liver dise...
Abbreviations: ALT = alanine aminotransferase, BMI = body-mass index, CHB = chronic hepatitis B, CHC...
<div><p>Objectives</p><p>To explore the relationship between non-alcoholic fatty liver disease (NAFL...
Metabolic syndrome (MetS) is a disease composed of different risk factors such as obesity, type 2 di...
The prevalence of diabetes is increasing rapidly in China. However, evidence is limited about its ef...
Non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MS) are two different entities sha...
The conventional paradigm of nonalcoholic fatty liver disease representing the "hepatic manifestatio...